English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Patients with cancer are frequently in a hypercoagulable state and the reported incidences of venous thromboembolism (VTE) and arterial thrombosis in patients with cancer are 4–20% and 2–5%, respectively (1-3). In particular, VTE is associated with worse prognosis in patients with cancer (4,5); therefore, extensive investigations have been performed for the development of useful risk assessment models, identification of better VTE biomarkers, and exploration of efficient therapeutic interventions.

Chemotherapy induced changes to fibrin clots properties in lung cancer: is it favorable?